According to the CDC, “RSV is the leading cause of bronchiolitis (inflammation of the small airways in the lungs) and pneumonia in children under 1 year old.” For people over the age of 65, RSV is also a leading cause of hospitalization and death.
Despite its prevalence, there is no vaccine for RSV and no cure. Treatment options are limited to symptom relief. One of the most effective treatments for RSV is ribavirin, which is typically administered through nebulization.
Unfortunately, there has been a recent shortage of ribavirin in the United States. The shortage is due to manufacturing and quality issues at one of the main suppliers of the drug. The CDC is urging health care providers to be vigilant in their RSV surveillance and to use available data to make decisions about when to start and end ribavirin therapy.
The agency is also working with the Food and Drug Administration (FDA) to increase production of the drug.
The shortage of ribavirin comes at a critical time, as RSV season is just beginning. RSV typically occurs in the winter months, peaking in February.
1. RSV is a serious virus that can cause severe respiratory illness in young children
According to the Centers for Disease Control and Prevention (CDC), RSV is the leading cause of bronchiolitis (inflammation of the small airways in the lungs) and pneumonia (lung infection) in children under one year old.
RSV usually starts out like a common cold, with symptoms such as a runny nose, cough, and fever. However, it can quickly worsen, leading to difficulty breathing and pneumonia. In severe cases, RSV can be fatal, particularly in young infants.
There is no specific treatment for RSV, and there is no vaccine to prevent it. The best way to protect your child from RSV is to wash your hands often, avoid close contact with people who are sick, and clean and disinfect frequently touched surfaces.
Unfortunately, RSV Season is just around the corner, and this year could be particularly bad due to a shortage of a key medication used to treat it.
The medication, palivizumab, is given as a monthly injection to high-risk infants to help prevent severe RSV disease. It is typically given during the RSV season, which runs from November to March.
The shortage is due to manufacturing delays, and it is not yet clear how long it will last. In the meantime, doctors are being advised to ration the medication and to prioritize infants who are at the highest risk for severe RSV disease, such as those born prematurely or with certain heart or lung conditions.
If you have an infant at home, it is important to be vigilant for any signs of respiratory illness. If your child develops a cold or other respiratory symptoms, be sure to contact your child’s doctor right away. Early diagnosis and treatment of RSV can help to prevent severe disease.
2. RSV outbreaks typically occur in the winter months
Since the 1950s, cases of respiratory syncytial virus (RSV) infection have been monitored in the U.S. RSV is a common virus that infects the respiratory tract and is the leading cause of bronchiolitis (inflammation of the small airways in the lungs) and pneumonia in infants and young children. RSV outbreaks typically occur in the winter months, with the majority of cases occurring in children under the age of two.
In recent years, there have been several drug shortages that have affected the availability of RSV medications. In 2014, there was a shortage of the RSV immunoglobulin G (IgG) antibody, which is used to treat infants who are at high risk for RSV infection. The shortage was caused by increased demand and a manufacturing delay.
In 2015, there was a shortage of the RSV monoclonal antibody palivizumab (Synagis), which is used to prevent RSV infection in high-risk infants. The shortage was caused by a decrease in the production of the antibody.
The shortages of these RSV medications have led to a decrease in the number of infants who are being treated for RSV. This could result in an increase in the number of RSV infections this winter.
It is important for parents to be aware of the symptoms of RSV. Symptoms include wheezing, coughing, fast breathing, and difficulty eating. If your child has any of these symptoms, you should contact your child's healthcare provider.
There are some steps that you can take to help prevent the spread of RSV. These steps include washing your hands often, avoiding close contact with people who are sick, and disinfecting surfaces that may be contaminated with the virus.
If you think your child has RSV, it is important to seek medical attention as soon as possible. Early diagnosis and treatment can help to prevent serious complications from the virus.
3. New drug shortages could mean a bad RSV season
American children could be in for a tough respiratory syncytial virus (RSV) season this year, as a new wave of drug shortages are hitting hospitals across the country.
The shortages are being caused by manufacturing problems at two of the country's largest suppliers of RSV vaccines. One of the suppliers, Sanofi Pasteur, has been unable to ship its RSVPure vaccine since early October, while the other, GlaxoSmithKline, has had supply issues with its RSV-2 vaccine since August.
This has left hospitals in a bind, as they are now left with only one approved RSV vaccine to give to infants and young children. And with RSV season typically starting in November, many are concerned that there won't be enough of the vaccine to go around.
The American Academy of Pediatrics has already issued a statement urging parents to get their children vaccinated as soon as possible, as the risk of RSV infection is highest for infants and young children. They also recommend that children who are at high risk for RSV, such as those with heart or lung conditions, be vaccinated as well.
While it's still too early to know how severe this year's RSV season will be, the situation is certainly a cause for concern. So if you have a young child, be sure to talk to your doctor about getting them vaccinated as soon as possible.
4. Drug shortages are becoming more common due to manufacturing problems and the globalization of the drug supply
The globalization of the drug supply has led to more drug shortages, as manufacturing problems arise in different parts of the world. Drug shortages can have a significant impact on patients, as they may not be able to get the medications they need. This can be especially difficult for patients with chronic conditions who rely on specific drugs to manage their condition.
One of the biggest concerns during a drug shortage is ensuring that patients have access to the medications they need. Hospitals and pharmacists may have to ration drugs, which can lead to difficult decisions about who gets the limited supply of medication. This can be a particular problem for drugs that are used to treat life-threatening conditions, as there may not be enough to go around.
Another concern is that drug shortages may lead to an increase in medication errors. When hospitals and pharmacists are rushed, they may be more likely to make mistakes. This can be dangerous for patients, as even a small error can have serious consequences.
Drug shortages can have a significant impact on the healthcare system and on patients. It is important to be aware of the potential problems that can arise during a drug shortage and to plan accordingly.
5. The FDA has been working to mitigate drug shortages
The FDA has been working to mitigate drug shortages caused by the coronavirus pandemic. The shortages have been caused by a combination of increased demand and supply disruptions.
The FDA has taken several steps to try to mitigate these shortages. They have waived certain regulations to allow imported drugs to be used in the US. They have also worked with manufacturers to increase production of drugs.
Despite these efforts, there are still some shortages. The FDA is urging healthcare providers to use clinical judgment when making decisions about which drugs to use. They are also working with other federal agencies to try to address the shortages.
6. However, new shortages are still occurring
Although the United States has been able to avoid severe drug shortages in recent years, new shortages are still occurring. According to the American Society of Health-System Pharmacists, there were reports of shortages of more than 400 different drugs in 2017, including some drugs used to treat life-threatening conditions such as cancer and heart disease.
One reason for the continued shortages is that the number of FDA-approved drugs has increased in recent years, while the number of manufacturing facilities has remained relatively unchanged. This means that any problems at a single facility can lead to shortages of multiple drugs.
Another reason for the shortages is that many drugs are now made using complex manufacturing processes that are difficult to replicate. This can make it difficult for other manufacturers to step in and produce the drug if there is a problem at the primary facility.
The shortages can result in significant problems for patients and doctors. In some cases, patients may have to ration their use of a life-saving drug or switch to a less effective alternative. This can put them at risk for serious complications or even death.
The shortages can also cause delays in care, as doctors may have to wait for drugs to become available before they can treat their patients. In some cases, patients may have to be discharged from the hospital before they are well enough to go home because of drug shortages.
The best way to avoid drug shortages is to plan ahead. Hospitals and other healthcare facilities should work with their suppliers to ensure that they have a steady supply of all the drugs they need. They should also have contingency plans in place in case a shortage does occur.
If you are a patient, you can ask your doctor or pharmacist about the possibility of shortages and what alternatives are available if a drug you need is not available.
7. Parents should be aware of the symptoms of RSV and seek medical treatment if their child becomes ill
Each year, thousands of babies in the United States are hospitalized with severe respiratory illnesses caused by respiratory syncytial virus, or RSV. This virus is highly contagious and can cause severe symptoms in young infants, including pneumonia and bronchiolitis. Symptoms of RSV include coughing, wheezing, difficulty breathing, and fever.
Most RSV infections occur in the fall and winter, and the virus can cause outbreaks in daycare centers and hospitals. Parents should be aware of the symptoms of RSV and seek medical treatment if their child becomes ill. Early treatment of RSV with antiviral medications can help to prevent severe illness.
If your child has symptoms of RSV, contact your healthcare provider. You should also keep your child away from other children and people with respiratory illnesses. Wash your hands often and clean surfaces that may be contaminated with the virus.
By following these simple precautions, you can help to protect your child from RSV and other respiratory viruses.
No one knows for sure why there has been an increase in drug shortages, but the most likely reason is that the industry has become more consolidated and there are fewer companies making these drugs. This shortage could not have come at a worse time, as we are in the middle of RSV season.
0 Comments